U.S. Markets closed

Oramed initiates patent recruitment for ORMD-0801 clinical trial

Oramed Pharmaceuticals announced that it has initiated patient recruitment for a new clinical trial of its orally ingestible insulin capsule, ORMD-0801 for patients with type 1 diabetes mellitus in Israel. Prior clinical studies have shown that ORMD-0801 administered to T1DM patients just prior to a meal effectively kept their blood sugar levels stable.